Who has stock in leucovorin?

What does it mean to “have stock in leucovorin”?

Leucovorin (also called folinic acid) is a generic medicine used in chemotherapy and related regimens. In most cases, people mean one of two things:

1) They want to know which publicly traded companies manufacture or sell leucovorin (so the companies’ shareholders effectively have exposure to the product market).
2) They want to know which investors or funds specifically hold shares of a company that produces leucovorin.

Neither “leucovorin” itself nor the drug’s generic ingredient has stock—only the companies that make it do.

Which publicly traded companies make leucovorin?

From the information provided here, there isn’t enough detail to name specific manufacturers/sellers of leucovorin and confirm which of them are publicly traded.

If you share either:
- the brand name(s) you mean (for example, how it appears on your prescription or in the market), or
- your country (US/EU/Canada, etc.),

I can narrow to the relevant manufacturers and then identify which are publicly traded.

How can you check who owns stock in a leucovorin-making company?

Common ways to research this include:
- Company investor holdings databases (for institutional owners)
- 13F filings (US) for large institutional investors and funds
- Portfolio trackers that show top holders (where available)

Quick clarification so I can give a precise answer

Which one are you asking for?
- A) “Which public companies sell leucovorin (so their shareholders indirectly have exposure)?”
- B) “Which specific investors/funds own shares in a company that sells leucovorin?”

Also tell me the market (US or another country) and any brand name tied to the leucovorin you’re referring to.